227 related articles for article (PubMed ID: 22726823)
21. Perindopril, a centrally active angiotensin-converting enzyme inhibitor, prevents cognitive impairment in mouse models of Alzheimer's disease.
Dong YF; Kataoka K; Tokutomi Y; Nako H; Nakamura T; Toyama K; Sueta D; Koibuchi N; Yamamoto E; Ogawa H; Kim-Mitsuyama S
FASEB J; 2011 Sep; 25(9):2911-20. PubMed ID: 21593435
[TBL] [Abstract][Full Text] [Related]
22. The role of the brain renin-angiotensin system in neurodegenerative disorders.
Savaskan E
Curr Alzheimer Res; 2005 Jan; 2(1):29-35. PubMed ID: 15977987
[TBL] [Abstract][Full Text] [Related]
23. Central angiotensin converting enzyme facilitates memory impairment in intracerebroventricular streptozotocin treated rats.
Tota S; Kamat PK; Saxena G; Hanif K; Najmi AK; Nath C
Behav Brain Res; 2012 Jan; 226(1):317-30. PubMed ID: 21864581
[TBL] [Abstract][Full Text] [Related]
24. Angiotensin AT(1) receptor signalling modulates reparative angiogenesis induced by limb ischaemia.
Emanueli C; Salis MB; Stacca T; Pinna A; Gaspa L; Madeddu P
Br J Pharmacol; 2002 Jan; 135(1):87-92. PubMed ID: 11786483
[TBL] [Abstract][Full Text] [Related]
25. Should angiotensin II receptor blockers and statins be combined?
Nickenig G
Circulation; 2004 Aug; 110(8):1013-20. PubMed ID: 15326080
[No Abstract] [Full Text] [Related]
26. Inhibition of the renin-angiotensin system abolishes the proatherogenic effect of uremia in apolipoprotein E-deficient mice.
Bro S; Binder CJ; Witztum JL; Olgaard K; Nielsen LB
Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1080-6. PubMed ID: 17347482
[TBL] [Abstract][Full Text] [Related]
27. Recent changes in the landscape of combination RAS blockade.
Epstein BJ; Smith SM; Choksi R
Expert Rev Cardiovasc Ther; 2009 Nov; 7(11):1373-84. PubMed ID: 19900020
[TBL] [Abstract][Full Text] [Related]
28. Exaggeration of focal cerebral ischemia in transgenic mice carrying human Renin and human angiotensinogen genes.
Inaba S; Iwai M; Tomono Y; Senba I; Furuno M; Kanno H; Okayama H; Mogi M; Higaki J; Horiuchi M
Stroke; 2009 Feb; 40(2):597-603. PubMed ID: 19023100
[TBL] [Abstract][Full Text] [Related]
29. Angiotensin receptors: a new role in cancer?
Deshayes F; Nahmias C
Trends Endocrinol Metab; 2005 Sep; 16(7):293-9. PubMed ID: 16061390
[TBL] [Abstract][Full Text] [Related]
30. The renin-angiotensin system and the developing retinal vasculature.
Sarlos S; Wilkinson-Berka JL
Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):1069-77. PubMed ID: 15728567
[TBL] [Abstract][Full Text] [Related]
31. Small but powerful: short peptide hormones and their role in autoimmune inflammation.
Lühder F; Lee DH; Gold R; Stegbauer J; Linker RA
J Neuroimmunol; 2009 Dec; 217(1-2):1-7. PubMed ID: 19748684
[TBL] [Abstract][Full Text] [Related]
32. Angiotensin AT1-receptor blockers and cerebrovascular protection: do they actually have a cutting edge over angiotensin-converting enzyme inhibitors?
Oprisiu-Fournier R; Faure S; Mazouz H; Boutitie F; Serot JM; Achard JM; Godefroy O; Hanon O; Temmar M; Albu A; Strandgaard S; Wang J; Black SE; Fournier A
Expert Rev Neurother; 2009 Sep; 9(9):1289-305. PubMed ID: 19769445
[TBL] [Abstract][Full Text] [Related]
33. Angiotensin II receptors are expressed and functional in human esophageal mucosa.
Casselbrant A; Edebo A; Hallersund P; Spak E; Helander HF; Jönson C; Fändriks L
Am J Physiol Gastrointest Liver Physiol; 2009 Nov; 297(5):G1019-27. PubMed ID: 19779016
[TBL] [Abstract][Full Text] [Related]
34. Reinventing the ACE inhibitors: some old and new implications of ACE inhibition.
Hanif K; Bid HK; Konwar R
Hypertens Res; 2010 Jan; 33(1):11-21. PubMed ID: 19911001
[TBL] [Abstract][Full Text] [Related]
35. Targeting brain Renin-Angiotensin System for the prevention and treatment of Alzheimer's disease: Past, present and future.
Gouveia F; Camins A; Ettcheto M; Bicker J; Falcão A; Cruz MT; Fortuna A
Ageing Res Rev; 2022 May; 77():101612. PubMed ID: 35346852
[TBL] [Abstract][Full Text] [Related]
36. The role of the renin-angiotensin system in thoracic aortic aneurysms: clinical implications.
Moltzer E; Essers J; van Esch JH; Roos-Hesselink JW; Danser AH
Pharmacol Ther; 2011 Jul; 131(1):50-60. PubMed ID: 21504760
[TBL] [Abstract][Full Text] [Related]
37. [What have we learned from converting enzyme inhibitors on renin-angiotensin system?].
Waeber B; Nussberger J; Brunner HR
Rev Prat; 1992 Dec; 42(20):2529-32. PubMed ID: 1338608
[TBL] [Abstract][Full Text] [Related]
38. Renin-angiotensin-aldosterone system blockade and renal protection: angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers?
Ruilope LM
Acta Diabetol; 2005 Apr; 42 Suppl 1():S33-41. PubMed ID: 15868118
[TBL] [Abstract][Full Text] [Related]
39. Serum levels of renin-angiotensin system components in acute stroke patients.
Mogi M; Kawajiri M; Tsukuda K; Matsumoto S; Yamada T; Horiuchi M
Geriatr Gerontol Int; 2014 Oct; 14(4):793-8. PubMed ID: 24279732
[TBL] [Abstract][Full Text] [Related]
40. Protective arms of the renin-angiotensin-system in neurological disease.
Sumners C; Horiuchi M; Widdop RE; McCarthy C; Unger T; Steckelings UM
Clin Exp Pharmacol Physiol; 2013 Aug; 40(8):580-8. PubMed ID: 23735163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
